TP73-AS1 promotes TMZ resistance in GBM CSC and is linked to regulation of the expression of metabolism-related genes and ALDH1A1, a protein known to be expressed in cancer stem cell markers and which protects GBM CSC from TMZ treatment [16]. The gene discussed is ALDH1A1; the disease is glioblastoma.